MedTrace Logo

Facial Emotion Recognition in Patients With Euthymic Bipolar Disorder I and II

NCT05922956 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-11-19

No results posted yet for this study

Summary

The facial emotion recognition is a basic social skill for successful social interactions. Several meta-analyses and recent studies found impairments of the perception of facial emotions in patients with euthymic bipolar disorder. Few studies compared recognition of facial emotions impairments during euthymia in patients with bipolar disorder type 1 and 2. These studies included low population samples (N\<60). There were discrepancies in results of these studies. Szanto suggested that facial emotion recognition impairments were correlated with suicidal risk and social isolation. These impairments should be taking into account regarding psycho-social treatments in patients with bipolar disorder.

This study aims to evaluate facial emotion recognition in patients with bipolar I and II disorders compared to healthy controls, using the facial emotion recognition test (TREF). The objective of the present study is to compare TREF scores in a group of patients with bipolar 1, a group of patients with bipolar 2 disorder and a group with healthy controls. In addition, the investigators will investigate the relationships between TREF scores and levels of self-esteem and mental well-being.

Conditions

  • Social Cognition
  • Facial Emotion Recognition
  • Facial Affect
  • Bipolar Disorder I and II

Interventions

OTHER

Facial emotion recognition test

Facial emotion recognition test (TREF), questionnaires including self-administered questionnaires

Sponsors & Collaborators

  • Centre Hospitalier le Vinatier

    collaborator UNKNOWN

  • Pôle Ressource Évaluation et Réhabilitation Psycho-sociale, EPSM de l'Oise

    collaborator UNKNOWN

  • Centre de santé mentale MGEN

    collaborator UNKNOWN

  • Centre Hospitalier Philippe Pinel, Amiens

    collaborator UNKNOWN

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2023-05-01
Completion
2023-07-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05922956 on ClinicalTrials.gov